Development of AECOPD identification tool (DETECT study)

Study identifier:D5252R00002

ClinicalTrials.gov identifier:NCT03556475

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A diagnostic test to develop an AECOPD identification tool through characteristic variables extracted from diagnosed AECOPD patients

Medical condition

Acute exacerbations of COPD

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

300

Study type

Observational

Age

N/A

Date

Study Start Date: 28 Apr 2020
Primary Completion Date: 18 Jan 2021
Study Completion Date: 18 Jan 2021

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Apr 2022 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria